Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Istaroxime

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Windtree Secures Istaroxime Patent Allowance For Acute Heart Failure
    Windtree Secures Istaroxime Patent Allowance For Acute Heart Failure

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036439/0/en/Windtree-Announces-Istaroxime-Notice-of-Allowance-from-the-U-S-Patent-and-Trademark-Office-for-Acute-Heart-Failure.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    Windtree To Present Istaroxime Data At Heart Failure Conference
    Windtree To Present Istaroxime Data At Heart Failure Conference

    12 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/12/3024995/0/en/Windtree-Announces-Special-Late-Breaking-Clinical-Science-Abstract-Presentation-on-Istaroxime-at-the-Technology-and-Heart-Failure-Therapeutics-Conference.html

    GLOBENEWSWIRE
    12 Feb 2025
    Share Share
    Windtree Files New Istaroxime Patent for Myocardial Arrhythmia
    Windtree Files New Istaroxime Patent for Myocardial Arrhythmia

    09 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/09/2993691/0/en/Windtree-Announces-New-Istaroxime-Patent-Filing-for-Preventing-or-Reducing-the-Risk-of-Acute-Myocardial-Arrhythmia.html

    GLOBENEWSWIRE
    09 Dec 2024
    Share Share
    Windtree Partners for Potential Strategic Deal in Cardiogenic Shock
    Windtree Partners for Potential Strategic Deal in Cardiogenic Shock

    04 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/04/2991425/0/en/Windtree-Announces-Partnership-with-New-Growth-Advisors-to-Leverage-Positive-Phase-2-Istaroxime-Study-in-Cardiogenic-Shock-for-a-Potential-Strategic-Transaction.html

    GLOBENEWSWIRE
    04 Dec 2024
    Share Share
    Windtree Therapeutic Initiates Seismic C Study in Cardiogenic Shock
    Windtree Therapeutic Initiates Seismic C Study in Cardiogenic Shock

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2971647/0/en/Windtree-Therapeutics-Initiates-SEISMiC-C-Study-of-Istaroxime-in-SCAI-Stage-C-Cardiogenic-Shock-for-Planned-Completion-of-Phase-2b-and-Transition-to-Phase-3.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share
    Windtree Announces Publication Of Istaroxime Phase 2b Design
    Windtree Announces Publication Of Istaroxime Phase 2b Design

    09 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//en/news-release/2024/10/09/2960460/0/en/Windtree-Announces-Publication-of-Positive-Istaroxime-Phase-2b-Study-Trial-Design.html

    GLOBENEWSWIRE
    09 Oct 2024
    Share Share